114 related articles for article (PubMed ID: 1364936)
41. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
42. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
[TBL] [Abstract][Full Text] [Related]
43. Comparison of gastrointestinal blood loss induced by cloximate in two formulations and by naproxen.
Rameis H; Hitzenberger G; Liem KS; Hulkenberg-Tromp D
Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):96-8. PubMed ID: 6365812
[TBL] [Abstract][Full Text] [Related]
44. NSAID-associated gastrointestinal damage: methodological considerations and a review of the experience with enteric coated naproxen.
Aabakken L
Eur J Rheumatol Inflamm; 1992; 12(2):9-20. PubMed ID: 1364941
[TBL] [Abstract][Full Text] [Related]
45. Duration of morning stiffness in rheumatic patients after medication with enteric-coated and plain naproxen tablets.
Johnsen V; Bjerkhoel F; Bjørneboe O; Børresen B; Finstad R; Hansen K; Moen F
Scand J Rheumatol; 1986; 15(1):37-40. PubMed ID: 3515526
[TBL] [Abstract][Full Text] [Related]
46. Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Canadian Multicentre Study Group.
Curr Med Res Opin; 1988; 11(1):16-27. PubMed ID: 2898319
[TBL] [Abstract][Full Text] [Related]
47. Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.
Goldstein JL; Hochberg MC; Fort JG; Zhang Y; Hwang C; Sostek M
Aliment Pharmacol Ther; 2010 Aug; 32(3):401-13. PubMed ID: 20497139
[TBL] [Abstract][Full Text] [Related]
48. A comparative study of Butacote and naproxen in ankylosing spondylitis.
Ansell BM
J Int Med Res; 1977; 5 Suppl 2():95. PubMed ID: 334610
[No Abstract] [Full Text] [Related]
49. Comparison of a slow-release indomethacin tablet and naproxen in osteoarthrosis.
Gordin A; Sotka S; Nuutila J
Curr Med Res Opin; 1985; 9(7):500-4. PubMed ID: 3896659
[TBL] [Abstract][Full Text] [Related]
50. Naproxen in osteoarthrosis. Double-blind crossover trial.
Blechman W; Willkens R; Boncaldo GL; Hoffmeister RT; Lockie LM; Multz C
Ann Rheum Dis; 1978 Feb; 37(1):80-4. PubMed ID: 343726
[TBL] [Abstract][Full Text] [Related]
51. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
Wilding IR; Hardy JG; Sparrow RA; Davis SS; Daly PB; English JR
Pharm Res; 1992 Nov; 9(11):1436-41. PubMed ID: 1475230
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of a single daily dose of naproxen in osteoarthritis.
Brooks PM; Cleland LG; Haski AL; Hempton DB; Muller JN; Hills LJ
Rheumatol Rehabil; 1982 Nov; 21(4):242-6. PubMed ID: 6753090
[TBL] [Abstract][Full Text] [Related]
53. Improved cost-effectiveness ratio with a patient self-adjusted naproxen dosing regimen in osteoarthritis treatment.
Kvien TK; Brørs O; Staff PH; Rognstad S; Nordby J
Scand J Rheumatol; 1991; 20(4):280-7. PubMed ID: 1925416
[TBL] [Abstract][Full Text] [Related]
54. A comparison of benorylate and naproxen in degenerative arthritis.
Mayhew SR
Rheumatol Rehabil; 1978 Feb; 17(1):29-33. PubMed ID: 32609
[TBL] [Abstract][Full Text] [Related]
55. An open study of 1.5 g naproxen daily in osteoarthritis.
Berry H; Nicholls A
Curr Med Res Opin; 1985; 9(6):366-70. PubMed ID: 3886299
[TBL] [Abstract][Full Text] [Related]
56. Butacote: the first assessment in general practice.
Rushford WA; Fowler PD
J Int Med Res; 1977; 5 Suppl 2():67-9. PubMed ID: 334607
[TBL] [Abstract][Full Text] [Related]
57. Naproxen and diflunisal in osteoarthrosis.
Brooks PM; Dougan MA; Thomas D; Hills LJ; Smith PJ
Rheumatol Rehabil; 1982 May; 21(2):95-7. PubMed ID: 7043712
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of an enteric-coated naproxen pellet formulation.
Hardy JG; Lamont GL; Evans DF; Haga AK; Gamst ON
Aliment Pharmacol Ther; 1991 Feb; 5(1):69-75. PubMed ID: 1932483
[TBL] [Abstract][Full Text] [Related]
59. Oral naproxen formulations.
Gamst ON
Scand J Gastroenterol Suppl; 1989; 163():44-7. PubMed ID: 2814363
[TBL] [Abstract][Full Text] [Related]
60. A multicenter study of the safety and efficacy of naproxen: analysis of blood pressure.
Goldberg MA
Semin Arthritis Rheum; 1988 Feb; 17(3 Suppl 2):23-8. PubMed ID: 3334107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
